| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 673.912.280 $ | +156.886.866 $ | +498,5 % | 10 | 551.578.345 $ | +193.024.571 $ | +233,7 % | 8 | 421.887.793 $ | +197.022.358 $ | +164,0 % | 7 | ||||
| Abivax S.A. | ABVX | → 0 | Schwach | 160.123.416 $ | -17.524.986 $ | -9,9 % | 1 | 177.648.402 $ | +62.963.275 $ | +54,9 % | 1 | 114.685.127 $ | +91.189.376 $ | +388,1 % | 1 |
| Protagonist Therapeutics, Inc | PTGX | → 0 | Neutral | 104.780.143 $ | +13.145.810 $ | +14,3 % | 1 | 91.634.333 $ | +25.922.973 $ | +39,4 % | 1 | 65.711.360 $ | +13.311.586 $ | +25,4 % | 1 |
| Roivant Sciences Ltd. | ROIV | → 0 | Schwach | 91.019.596 $ | +16.611.121 $ | +22,3 % | 1 | 74.408.475 $ | +23.760.785 $ | +46,9 % | 1 | 50.647.690 $ | +28.774.908 $ | +131,6 % | 1 |
| Keros Therapeutics, Inc. | KROS | → 0 | Stark | 85.258.156 $ | +13.311.482 $ | +18,5 % | 1 | ||||||||
| Immunovant, Inc. | IMVT | → 0 | Schwach | 66.546.608 $ | +3.480.401 $ | +5,5 % | 1 | 63.066.207 $ | +26.929.149 $ | +74,5 % | 1 | 36.137.058 $ | +27.576.002 $ | +322,1 % | 1 |
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 58.766.931 $ | +36.885.685 $ | +168,6 % | 1 | |||||||||
| CYTOKINETICS INC | CYTK | → 0 | Schwach | 41.691.766 $ | +7.369.618 $ | +21,5 % | 1 | 34.322.148 $ | +5.802.250 $ | +20,3 % | 1 | ||||
| Crinetics Pharmaceuticals, Inc. | CRNX | → 0 | Neutral | 41.380.502 $ | +26.979.422 $ | +187,3 % | 1 | ||||||||
| Avidity Biosciences, Inc. | RNA | → 0 | 39.421.497 $ | +37.083.705 $ | +1.586,3 % | 1 | |||||||||
| Morse Asset Management, Inc | → 0 | 39.204.266 $ | +401.178 $ | +1,0 % | 1 | 38.803.088 $ | +418.035 $ | +1,1 % | 1 | 38.385.053 $ | +397.808 $ | +1,0 % | 1 | ||
| Denali Therapeutics Inc. | DNLI | → 0 | Stark | 35.931.936 $ | +35.071.501 $ | +4.076,0 % | 1 | ||||||||
| Beam Therapeutics Inc. | BEAM | → 0 | Neutral | 34.467.116 $ | +34.467.116 $ | 1 | |||||||||
| Septerna, Inc. | SEPN | → 0 | Neutral | 32.274.195 $ | +10.144.399 $ | +45,8 % | 1 | ||||||||
| 89bio, Inc. | → 0 | 31.063.349 $ | +22.461.196 $ | +261,1 % | 1 | ||||||||||
| 673.912.280 $ | +156.886.866 $ | +498,5 % | 10 | 551.578.345 $ | +193.024.571 $ | +233,7 % | 8 | 421.887.793 $ | +197.022.358 $ | +164,0 % | 7 | ||||